Drugs / human granulocyte colony-stimulating factor
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT06734520 Background | Oct 2024 → Jul 2029 expected | beta-thalassemia major | Guangzhou Women and Children's Medical Center | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | human granulocyte colony-stimulating factor | “human granulocyte colony-stimulating factor (G-CSF)” NCT06734520 ↗ |
| Known as | G-CSF | “human granulocyte colony-stimulating factor (G-CSF)” NCT06734520 ↗ |
| Route | Subcutaneous | “donors are mobilized subcutaneously for five days with human granulocyte colony-stimulating factor (G-CSF)” NCT06734520 ↗ |